Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges
Authors
Keywords
-
Journal
JOURNAL OF NANOBIOTECHNOLOGY
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-29
DOI
10.1186/s12951-021-00864-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The β-secretase BACE1 in Alzheimer’s disease
- (2020) Harald Hampel et al. BIOLOGICAL PSYCHIATRY
- Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
- (2020) Carina Wattmo et al. BMC Neurology
- Recent advances on anti-tumor agents-loaded polymeric and lipid based nano-carriers for the treatment of brain cancer
- (2020) Amanda Cano et al. CURRENT PHARMACEUTICAL DESIGN
- Drug delivery across the blood–brain barrier: recent advances in the use of nanocarriers
- (2020) John JE Mulvihill et al. Nanomedicine
- Novel therapeutic strategies for Alzheimer's disease: Implications from cell-based therapy and nanotherapy
- (2020) Hossein Derakhshankhah et al. Nanomedicine-Nanotechnology Biology and Medicine
- Serum neurofilament light levels in normal aging and their association with morphologic brain changes
- (2020) Michael Khalil et al. Nature Communications
- Metal-Based Nanoparticles as Antimicrobial Agents: An Overview
- (2020) Elena Sánchez-López et al. Nanomaterials
- Astrocyte and Oligodendrocyte Cross-Talk in the Central Nervous System
- (2020) Erik Nutma et al. Cells
- Therapeutic Potential of Direct Clearance of the Amyloid-β in Alzheimer’s Disease
- (2020) Dong Eun Kim et al. Brain Sciences
- Carbon dots sensitized lanthanide infinite coordination polymer nanoparticles: Towards ratiometric fluorescent sensing of cerebrospinal Aβ monomer as a biomarker for Alzheimer’s disease
- (2020) Chang Liu et al. ANALYTICA CHIMICA ACTA
- Quercetin lipid nanoparticles functionalized with transferrin for Alzheimer's disease
- (2020) R.G.R Pinheiro et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- New fluid biomarkers tracking non-amyloid-β and non-tau pathology in Alzheimer’s disease
- (2020) Sun Ah Park et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- A dual-ligand fusion peptide improves the brain-neuron targeting of nanocarriers in Alzheimer's disease mice
- (2020) Qian Guo et al. JOURNAL OF CONTROLLED RELEASE
- Novel biosensor for acetylcholine based on acetylcholinesterase/poly(neutral red) – Deep eutectic solvent/Fe2O3 nanoparticle modified electrode
- (2020) Wanderson da Silva et al. JOURNAL OF ELECTROANALYTICAL CHEMISTRY
- TREM2 activation attenuates neuroinflammation and neuronal apoptosis via PI3K/Akt pathway after intracerebral hemorrhage in mice
- (2020) Shengpan Chen et al. Journal of Neuroinflammation
- Current advances in the development of novel polymeric nanoparticles for the treatment of neurodegenerative diseases
- (2020) Amanda Cano et al. Nanomedicine
- Novel peptide-conjugated nanomedicines for brain targeting: in vivo evidences
- (2020) J.T. Duskey et al. Nanomedicine-Nanotechnology Biology and Medicine
- Evaluation of neurological effects of cerium dioxide nanoparticles doped with different amounts of zirconium following inhalation exposure in mouse models of Alzheimer’s and vascular disease
- (2020) Tina Wahle et al. NEUROCHEMISTRY INTERNATIONAL
- A computerized version of the Short Form of the Face-Name Associative Memory Exam (FACEmemory®) for the early detection of Alzheimer’s disease
- (2020) Montserrat Alegret et al. Alzheimers Research & Therapy
- The potential role of pomegranate and its nano-formulations on cerebral neurons in aluminum chloride induced Alzheimer rat model
- (2020) Mohammed S. Almuhayawi et al. SAUDI JOURNAL OF BIOLOGICAL SCIENCES
- A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study
- (2020) Mercè Boada et al. Alzheimers & Dementia
- Early diagnosis of Alzheimer’s disease: the role of biomarkers including advanced EEG signal analysis. Report from the IFCN-sponsored panel of experts
- (2020) P.M. Rossini et al. CLINICAL NEUROPHYSIOLOGY
- Deciphering the anti-apoptotic potential of α-bisabolol loaded solid lipid nanoparticles against Aβ induced neurotoxicity in Neuro-2a cells
- (2020) Sethuraman Sathya et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation
- (2020) Michael Ewers et al. EMBO Molecular Medicine
- Cationic biopolymer functionalized nanoparticles encapsulating lutein to attenuate oxidative stress in effective treatment of Alzheimer’s disease: A non-invasive approach
- (2020) Namdev Dhas et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
- (2020) Sebastian Palmqvist et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A comprehensive review on green synthesis of nature-inspired metal nanoparticles: Mechanism, application and toxicity
- (2020) Anu Rana et al. JOURNAL OF CLEANER PRODUCTION
- Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer’s disease
- (2020) Nicolas R. Barthélemy et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Transferrin’ across the blood–brain barrier
- (2020) Joseph Willson NATURE REVIEWS DRUG DISCOVERY
- Longitudinal plasma p-tau217 is increased in early stages of Alzheimer’s disease
- (2020) Niklas Mattsson-Carlgren et al. BRAIN
- Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction
- (2019) Daniel A. Nation et al. NATURE MEDICINE
- Microglial Progranulin: Involvement in Alzheimer’s Disease and Neurodegenerative Diseases
- (2019) Anarmaa Mendsaikhan et al. Cells
- Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease
- (2019) Philip S. J. Weston et al. Alzheimers Research & Therapy
- Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer’s disease model
- (2019) Li Zhong et al. Nature Communications
- A Quarter Century of APOE and Alzheimer’s Disease: Progress to Date and the Path Forward
- (2019) Michaël E. Belloy et al. NEURON
- Genetic screening in early-onset Alzheimer's disease identified three novel presenilin mutations
- (2019) Tsz Hang Wong et al. NEUROBIOLOGY OF AGING
- SNAP-25 in Serum Is Carried by Exosomes of Neuronal Origin and Is a Potential Biomarker of Alzheimer’s Disease
- (2019) Cristina Agliardi et al. MOLECULAR NEUROBIOLOGY
- Sustained release of bioactive hydrogen by Pd hydride nanoparticles overcomes Alzheimer's disease
- (2019) Lei Zhang et al. BIOMATERIALS
- Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum
- (2019) Isabelle Bos et al. Alzheimers & Dementia
- Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study
- (2019) Alberto Lleó et al. Alzheimers & Dementia
- Search for biomarkers of Alzheimer‘s disease: Recent insights, current challenges and future prospects
- (2019) Kateřina Hrubešová et al. CLINICAL BIOCHEMISTRY
- Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model
- (2019) Amanda Cano et al. JOURNAL OF CONTROLLED RELEASE
- The role of astroglia in Alzheimer's disease: pathophysiology and clinical implications
- (2019) Amaia M Arranz et al. LANCET NEUROLOGY
- Vitamin D-binding protein-loaded PLGA nanoparticles suppress Alzheimer's disease-related pathology in 5XFAD mice
- (2019) Seong Gak Jeon et al. Nanomedicine-Nanotechnology Biology and Medicine
- Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease
- (2019) Niklas Mattsson et al. JAMA Neurology
- A metabolic perspective of late onset Alzheimer’s disease
- (2019) Miren Ettcheto et al. PHARMACOLOGICAL RESEARCH
- Protein-Capped Metal Nanoparticles Inhibit Tau Aggregation in Alzheimer’s Disease
- (2019) Shweta Kishor Sonawane et al. ACS Omega
- Quercetin-modified gold-palladium nanoparticles as a potential autophagy inducer for the treatment of Alzheimer's disease
- (2019) Yanan Liu et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- Magnetic nanoparticles in nanomedicine: a review of recent advances
- (2019) Kai Wu et al. NANOTECHNOLOGY
- Microglia in Alzheimer Disease: Well-Known Targets and New Opportunities
- (2019) Anne-Laure Hemonnot et al. Frontiers in Aging Neuroscience
- Neuroprotective effects of curcumin lipid-core nanocapsules in a model Alzheimer’s disease induced by β-amyloid 1-42 peptide in aged female mice
- (2019) Renata Giacomeli et al. BRAIN RESEARCH
- Phytol loaded PLGA nanoparticles regulate the expression of Alzheimer's related genes and neuronal apoptosis against amyloid-β induced toxicity in Neuro-2a cells and transgenic Caenorhabditis elegans
- (2019) Sethuraman Sathya et al. FOOD AND CHEMICAL TOXICOLOGY
- Preparation and in vitro evaluation of multi-target-directed selenium-chondroitin sulfate nanoparticles in protecting against the Alzheimer's disease
- (2019) Fei Gao et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Metal nanoparticles synthesis: An overview on methods of preparation, advantages and disadvantages, and applications
- (2019) Prasad Govindrao Jamkhande et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Methodological Issues in the Clinical Validation of Biomarkers for Alzheimer’s Disease: The Paradigmatic Example of CSF
- (2019) Marco Canevelli et al. Frontiers in Aging Neuroscience
- Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer’s disease
- (2019) Christopher D. Whelan et al. Acta Neuropathologica Communications
- Ultrasmall superparamagnetic iron oxide nanoparticles-bound NIR dyes: Novel theranostic agents for Alzheimer's disease
- (2019) Jing Cai et al. DYES AND PIGMENTS
- Improvement of memory deficits in the rat model of Alzheimer's disease by erythropoietin-loaded solid lipid nanoparticles
- (2019) Tahereh Dara et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study
- (2019) Virginia Pérez-Grijalba et al. Alzheimers Research & Therapy
- Anticholinergic Drugs in Geriatric Psychopharmacology
- (2019) Jorge López-Álvarez et al. Frontiers in Neuroscience
- Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography
- (2018) Michelle M. Mielke et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer’s Disease Dementia in Individuals With Mild Cognitive Impairment
- (2018) Yong Shen et al. BIOLOGICAL PSYCHIATRY
- Microglia-Mediated Neuroprotection, TREM2 , and Alzheimer’s Disease: Evidence From Optical Imaging
- (2018) Carlo Condello et al. BIOLOGICAL PSYCHIATRY
- The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
- (2018) Harald Hampel et al. BRAIN
- Tau Proteins and Tauopathies in Alzheimer’s Disease
- (2018) Fong Ping Chong et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
- (2018) Barbara Mroczko et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer’s Disease
- (2018) Che-Chuan Yang et al. JOURNAL OF ALZHEIMERS DISEASE
- α-Bisabolol loaded solid lipid nanoparticles attenuates Aβ aggregation and protects Neuro-2a cells from Aβ induced neurotoxicity
- (2018) Sethuraman Sathya et al. JOURNAL OF MOLECULAR LIQUIDS
- Biomarkers for Alzheimer Disease: Classical and Novel Candidates’ Review
- (2018) Nadia El Kadmiri et al. NEUROSCIENCE
- The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer’s disease
- (2018) Bianca A. Trombetta et al. PLoS One
- Use of statins and the risk of dementia and mild cognitive impairment: A systematic review and meta-analysis
- (2018) Che-Sheng Chu et al. Scientific Reports
- TREM2-Dependent Effects on Microglia in Alzheimer’s Disease
- (2018) Yingyue Zhou et al. Frontiers in Aging Neuroscience
- Phytol: A review of biomedical activities
- (2018) Muhammad Torequl Islam et al. FOOD AND CHEMICAL TOXICOLOGY
- Increased CSF-BACE1 Activity Associated with Decreased Hippocampus Volume in Alzheimer's Disease
- (2018) Michael Ewers et al. JOURNAL OF ALZHEIMERS DISEASE
- Vitamin D Binding Protein as a Serum Biomarker of Alzheimer's Disease
- (2018) Ram J. Bishnoi et al. JOURNAL OF ALZHEIMERS DISEASE
- Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease
- (2018) Andrew J. Aschenbrenner et al. NEUROLOGY
- APOE ε4 is associated with higher levels of CSF SNAP-25 in prodromal Alzheimer’s disease
- (2018) Shanshan Wang et al. NEUROSCIENCE LETTERS
- Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer’s disease
- (2018) Hua Zhang et al. Alzheimers Research & Therapy
- Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer’s disease
- (2018) Hua Zhang et al. Translational Neurodegeneration
- Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology
- (2018) Åsa Sandelius et al. Alzheimers & Dementia
- CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline
- (2018) Marc Suárez‐Calvet et al. EMBO Molecular Medicine
- Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release
- (2018) Aldemar Gordillo-Galeano et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Applications of Noble Metal-Based Nanoparticles in Medicine
- (2018) Bartosz Klębowski et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Blood-based biomarkers for Alzheimer’s disease—An update
- (2018) Henrik Zetterberg JOURNAL OF NEUROSCIENCE METHODS
- Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2018) Emma Nichols et al. LANCET NEUROLOGY
- Biomarkers for tau pathology
- (2018) Michael Schöll et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Cationic carrier peptide enhances cerebrovascular targeting of nanoparticles in Alzheimer's disease brain
- (2018) Kristen M. Ahlschwede et al. Nanomedicine-Nanotechnology Biology and Medicine
- Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer’s disease and other neurodegenerative diseases
- (2017) Filippo Baldacci et al. Expert Review of Proteomics
- A sensitive and selective electrochemical biosensor for the determination of beta-amyloid oligomer by inhibiting the peptide-triggered in situ assembly of silver nanoparticles
- (2017) Yun Xing et al. International Journal of Nanomedicine
- Polymeric nanoparticles: Promising platform for drug delivery
- (2017) Khalid M. El-Say et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer’s disease Neurons
- (2017) Ravi Rajmohan et al. JOURNAL OF ALZHEIMERS DISEASE
- Biomedical applications of green synthesized Nobel metal nanoparticles
- (2017) Zia Ul Haq Khan et al. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
- The Pharmacological Effects of Lutein and Zeaxanthin on Visual Disorders and Cognition Diseases
- (2017) Yu-Ping Jia et al. MOLECULES
- Addendum: The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2017) Jeff Sevigny et al. NATURE
- Early-Onset Alzheimer Disease
- (2017) Mario F. Mendez NEUROLOGIC CLINICS
- Neuroprotective effects of erythropoietin on Alzheimer’s dementia model in rats
- (2017) Betul Cevik et al. Advances in Clinical and Experimental Medicine
- Alzheimer’s Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid
- (2017) Rose Ann Huynh et al. Frontiers in Neurology
- BACE1 Activity in Cerebrospinal Fluid and Its Relation to Markers of AD Pathology
- (2017) Sandra D. Mulder et al. JOURNAL OF ALZHEIMERS DISEASE
- Gold nanoparticle-capped mesoporous silica-based H 2 O 2 -responsive controlled release system for Alzheimer’s disease treatment
- (2016) Licong Yang et al. Acta Biomaterialia
- Neuroinflammation in Alzheimer's disease: Current evidence and future directions
- (2016) Valeria Calsolaro et al. Alzheimers & Dementia
- Protective role of epigallocatechin-3-gallate in health and disease: A perspective
- (2016) Animesh Chowdhury et al. BIOMEDICINE & PHARMACOTHERAPY
- Tau and tauopathies
- (2016) Thomas Arendt et al. BRAIN RESEARCH BULLETIN
- Serum Levels of Progranulin Do Not Reflect Cerebrospinal Fluid Levels in Neurodegenerative Disease
- (2016) Carlo Wilke et al. Current Alzheimer Research
- Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer’s disease
- (2016) Simone Lista et al. Expert Review of Neurotherapeutics
- A Novel Liposomal Nanoparticle for the Imaging of Amyloid Plaque by Magnetic Resonance Imaging
- (2016) Eric A. Tanifum et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer’s Disease
- (2016) Piotr Lewczuk et al. JOURNAL OF ALZHEIMERS DISEASE
- Methods for the Specific Detection and Quantitation of Amyloid-β Oligomers in Cerebrospinal Fluid
- (2016) Judith Schuster et al. JOURNAL OF ALZHEIMERS DISEASE
- Alzheimer's disease: An overview of amyloid beta dependent pathogenesis and its therapeutic implications along with in silico approaches emphasizing the role of natural products
- (2016) Manika Awasthi et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Tratamiento de la enfermedad de Alzheimer mediante terapia combinada de aféresis terapéutica y hemoféresis con albúmina e inmunoglobulina intravenosa: fundamentos y aproximación terapéutica al estudio AMBAR (Alzheimer Management By Albumin Replacement)
- (2016) M. Boada et al. NEUROLOGIA
- The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease
- (2016) Annika Öhrfelt et al. Alzheimers Research & Therapy
- Mechanisms of Aβ Clearance and Degradation by Glial Cells
- (2016) Miriam Ries et al. Frontiers in Aging Neuroscience
- Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer’s disease
- (2016) Simone Lista et al. Expert Review of Neurotherapeutics
- Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease
- (2016) Rawan Tarawneh et al. JAMA Neurology
- Mitochondrial Dysfunction in Alzheimer’s Disease and the Rationale for Bioenergetics Based Therapies
- (2016) Isaac G. Onyango et al. Aging and Disease
- CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
- (2016) Shorena Janelidze et al. Annals of Clinical and Translational Neurology
- Estimation of Tau and Phosphorylated Tau181 in Serum of Alzheimer’s Disease and Mild Cognitive Impairment Patients
- (2016) Shashank Shekhar et al. PLoS One
- Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
- (2015) Kaj Blennow et al. Alzheimers & Dementia
- Agonists of the Tissue-Protective Erythropoietin Receptor in the Treatment of Parkinson’s Disease
- (2015) Juha Punnonen et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Controlled Drug Delivery: Historical perspective for the next generation
- (2015) Yeon Hee Yun et al. JOURNAL OF CONTROLLED RELEASE
- Importance of selenium and selenoprotein for brain function: From antioxidant protection to neuronal signalling
- (2015) Nikolay D. Solovyev JOURNAL OF INORGANIC BIOCHEMISTRY
- Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay
- (2015) Wendy E. Heywood et al. Molecular Neurodegeneration
- Surface charge-conversion polymeric nanoparticles for photodynamic treatment of urinary tract bacterial infections
- (2015) Shijie Liu et al. NANOTECHNOLOGY
- Vascular dysfunction in the pathogenesis of Alzheimer's disease — A review of endothelium-mediated mechanisms and ensuing vicious circles
- (2015) Luigi Yuri Di Marco et al. NEUROBIOLOGY OF DISEASE
- Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in Pharmacoresistant Schizophrenia Therapy
- (2015) Famida G. Hoosain et al. Biomed Research International
- Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease
- (2014) Cassia R. Overk et al. BIOCHEMICAL PHARMACOLOGY
- The blood-brain barrier: Structure, function and therapeutic approaches to cross it
- (2014) Marta Tajes et al. MOLECULAR MEMBRANE BIOLOGY
- Towards non-invasive diagnostic imaging of early-stage Alzheimer's disease
- (2014) Kirsten L. Viola et al. Nature Nanotechnology
- CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival
- (2014) T. Skillback et al. NEUROLOGY
- Nanoparticles as drug delivery systems
- (2014) Agnieszka Z. Wilczewska et al. Pharmacological Reports
- The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer’s disease
- (2014) Takahisa Kanekiyo et al. Frontiers in Aging Neuroscience
- Controlled drug delivery systems: the next 30 years
- (2014) Yeonhee Yun et al. Frontiers of Chemical Science and Engineering
- Glyconanoparticle Aided Detection of β-Amyloid by Magnetic Resonance Imaging and Attenuation of β-Amyloid Induced Cytotoxicity
- (2013) Hovig Kouyoumdjian et al. ACS Chemical Neuroscience
- Cerebrospinal fluid BACE1 activity and markers of amyloid precursor protein metabolism and axonal degeneration in Alzheimer's disease
- (2013) Robert Perneczky et al. Alzheimers & Dementia
- Emerging Research and Clinical Development Trends of Liposome and Lipid Nanoparticle Drug Delivery Systems
- (2013) John C. Kraft et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Therapeutics of Alzheimer's disease: Past, present and future
- (2013) R. Anand et al. NEUROPHARMACOLOGY
- Advances and new technologies applied in controlled drug delivery system
- (2013) Fatma Bassyouni et al. RESEARCH ON CHEMICAL INTERMEDIATES
- Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
- (2012) Subash C. Gupta et al. AAPS Journal
- Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine - searching for the connections
- (2012) Wojciech Danysz et al. BRITISH JOURNAL OF PHARMACOLOGY
- Chondroitin sulfate: A key molecule in the brain matrix
- (2012) J.C.F. Kwok et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Variant of TREM2 Associated with the Risk of Alzheimer's Disease
- (2012) Thorlakur Jonsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loss of orally administered drugs in GI tract
- (2012) Yogeshkumar Nanasaheb Gavhane et al. SAUDI PHARMACEUTICAL JOURNAL
- Alzheimer's disease
- (2011) Clive Ballard et al. LANCET
- Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
- (2011) Lydia Alvarez-Erviti et al. NATURE BIOTECHNOLOGY
- Nanolipidic particles improve the bioavailability and α-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease
- (2010) Adam Smith et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Revising the definition of Alzheimer's disease: a new lexicon
- (2010) Bruno Dubois et al. LANCET NEUROLOGY
- The Role of Metabolic Disorders in Alzheimer Disease and Vascular Dementia
- (2009) Suzanne Craft ARCHIVES OF NEUROLOGY
- Biodegradable polymeric nanoparticles based drug delivery systems
- (2009) Avnesh Kumari et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- A Review of the Application and Pharmacological Properties of α-Bisabolol and α-Bisabolol-Rich Oils
- (2009) Guy P. P. Kamatou et al. JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY
- Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease☆
- (2008) Annette Maczurek et al. ADVANCED DRUG DELIVERY REVIEWS
- CSF Multianalyte Profile Distinguishes Alzheimer and Parkinson Diseases
- (2008) Jing Zhang et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles
- (2008) Christian Wischke et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Etazolate, a neuroprotective drug linking GABAAreceptor pharmacology to amyloid precursor protein processing
- (2008) Maryline Marcade et al. JOURNAL OF NEUROCHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now